In the clinical evaluations to date, the dose of botulinum toxin type A used to treat gastroparesis ranged from 80 to 200 units. The pyloric sphincter was divided into equal anatomical quadrants, and ...

Botulinum Toxin Type A has become a pivotal agent in modern dermatology, finding applications that range from the correction of dynamic rhytides to adjunctive procedures in surgical settings.

The results suggest that the dual-modality approach of combining oral doxycycline with intradermal BTX type A is far more ...

The use of toxin botulinum-A is one of the most rapidly growing areas in cosmetic dermatology. There is always news about this incredible substance. There are new indications, new techniques, and new ...

CHICAGO, IL—The use of botulinum toxin type A in patients undergoing cardiac surgery does not seem to reduce the rate of postoperative atrial fibrillation (AF) overall, according to the phase II NOVA ...

Enterococci are hardy microbes that thrive in the gastrointestinal tracts of nearly all land animals, including our own, and generally cause no harm. But their ruggedness has lately made them leading ...

Please provide your email address to receive an email when new articles are posted on . Some botulinum toxin type A injection formulations have a faster onset, whereas others were shown to last longer ...

For people with idiopathic chronic non-obstructive urinary retention caused by external urethral sphincter dysfunction (also known as Fowler's syndrome in younger women and people with female anatomy, ...

U.S. regulators have issued warnings to 18 websites that were selling fake or unapproved versions of Botox and similar wrinkle-relaxing injections. The UK government on Thursday announced plans to ...